XML 154 R81.htm IDEA: XBRL DOCUMENT v3.22.4
Segmentation of key figures (Details 11) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of operating segments [line items]      
Profit sharing income $ 921 $ 873 $ 835
Royalty income 52 109 300
Milestone income 148 155 50
Other 162 114 54
Other revenues 1,283 1,251 1,239
Innovative Medicines      
Disclosure of operating segments [line items]      
Profit sharing income 921 873 835
Royalty income 28 74 107
Milestone income 145 127 39
Other 155 105 37
Other revenues 1,249 1,179 1,018
Sandoz      
Disclosure of operating segments [line items]      
Royalty income 18 24 25
Milestone income 3 28 11
Other 7 9 17
Other revenues 28 61 53
Corporate      
Disclosure of operating segments [line items]      
Royalty income 6 11 168
Other revenues $ 6 $ 11 $ 168